Novo Nordisk further slashes prices of Ozempic, Wegovy in India to better compete as generics enter

Reporting by Yagnoseni Das in Bengaluru; Editing by Devika Syamnath Our Standards: The Thomson Reuters Trust Principles., opens new tab Purchase Licensing Rights Business Novo Nordisk further slashes prices of Ozempic, Wegovy in India to better compete as generics enter | Reuters Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams Purchase ...